AKT1 and glioblastoma: Several dysregulated signaling pathways, such as Notch, NF-κB, PI3K/Akt/mTOR, and Wnt/β-catenin, are accountable for tumorigenesis and therapeutic resistance of GBM by GSCs (95-101).